Zymeworks Inc. — Director's Dealing 2022

Dec 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2022-12-22

Reporting Person: Galbraith Kenneth (Director, Chair & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-22	Restricted Stock Unit	$	A	100000	Acquired	2025-12-22	Common Stock (100000)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

F2: The RSUs vest on December 22, 2025.